C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2001
11/22/2001	WO2001087963A1 A new polypeptide- human ribosomal protein s18-12 and the polynucleotide encoding it
11/22/2001	WO2001087962A1 A new polypeptide-human pax protein 11 and the polynucleotide encoding it
11/22/2001	WO2001087961A1 A new polypeptide-human pax protein 11.4 and the polynucleotide encoding it
11/22/2001	WO2001087960A1 A new polypeptide-human kruppel-related dna-binding protein 10 and the polynucleotide encoding it
11/22/2001	WO2001087959A1 A new polypeptide-human pax protein 11.9 and the polynucleotide encoding it
11/22/2001	WO2001087956A1 A novel polypeptide - deae and deah box family atp-dependent helicase 50 and the polynucleotide encoding said polypeptide
11/22/2001	WO2001087955A1 A novel polypeptide-dna mismatch repair protein 10 and the polynucleotide encoding said polypeptide
11/22/2001	WO2001087954A1 A novel polypeptide, a human clathrin light chain 9 and the polynucleotide encoding the polypeptide
11/22/2001	WO2001087953A1 A novel polypeptide-homo galactokinase 11 and polynucleotide encoding said polypeptide
11/22/2001	WO2001087952A1 A novel polypeptide-homo ribosomal protein 13 and polynucleotide encoding said polypeptide
11/22/2001	WO2001087951A1 A novel polypeptide -homo helicase 11 and polynucleotide encoding said polypeptide
11/22/2001	WO2001087950A1 A novel polypeptide -human cannabinoid receptor 11 and the polynucleotide encoding said polypeptide
11/22/2001	WO2001087949A1 A novel polypeptide- human pax protein 9 and the polynucleotide encoding said polypeptide
11/22/2001	WO2001087948A1 A novel polypeptide -human aldehyde/ketoreductase 12 and the polynucleotide encoding said polypeptide
11/22/2001	WO2001087947A1 A novel polypeptide-human ccr4 protein 10 and the polynucleotide encoding said polypeptide
11/22/2001	WO2001087946A1 A novel polypeptide- homo ubiquitin-conjugated enzyme 11 and polynucleotide encoding said polypeptide
11/22/2001	WO2001087945A1 The novel polypeptide-human laminin b2 chain 12 and the polynucliotide encoding said polypeptide
11/22/2001	WO2001087944A1 A novel polypeptide-human protein 10 characterized in that it comprises the sequence of gamma glutamyl transpeptidase and the polynucleotide encoding said polypeptide
11/22/2001	WO2001087943A1 A novel polypeptide-human atp-dependent serine protease 13 and the polynucleotide encoding said polypeptide
11/22/2001	WO2001087942A1 A novel polypeptide -human phosphatidase 13 and the polynucleotide encoding said polypeptide
11/22/2001	WO2001087941A1 A novel polypeptide-human kringle protein 14 and the polynucleotide encoding said polypeptide
11/22/2001	WO2001087940A2 Polypeptide composionns toxic to anthonomus insects, and use thereof
11/22/2001	WO2001087938A2 Polynucleotide sequence encoding a putative cell adhesion molecule
11/22/2001	WO2001087937A2 G-protein coupled receptors
11/22/2001	WO2001087936A2 Isolation of micromonospora carbonacea var africana pmlp1 integrase and use of integrating function for site-specific integration into micromonospora halophitica and micromonospora carbonacea chromosome
11/22/2001	WO2001087935A2 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (pttg)
11/22/2001	WO2001087934A2 Treatment of neoplasia/transformation using a pituitary tumor transforming gene carboxy terminal peptides
11/22/2001	WO2001087933A2 Zsig33-like peptides
11/22/2001	WO2001087932A2 Seven transmembrane proteins and polynucleotides encoding the same
11/22/2001	WO2001087931A2 Bacterial insecticidal proteins
11/22/2001	WO2001087930A2 Human galanin receptor-like g protein coupled receptor
11/22/2001	WO2001087929A2 Regulation of human dopamine-like g protein-coupled receptor
11/22/2001	WO2001087925A2 Methods for refolding proteins containing free cysteine residues
11/22/2001	WO2001087923A1 Therapeutic approaches to diseases by suppression of the nurr subfamily of nuclear transcription factors
11/22/2001	WO2001087914A2 Plant gene targeting using oligonucleotides
11/22/2001	WO2001087911A1 Method of identifying critical points within protein-protein interactions
11/22/2001	WO2001087884A2 Polyketide derivatives
11/22/2001	WO2001087351A1 Method for treatment of tumors using nucleic acid ligands to pdgf
11/22/2001	WO2001087350A2 Treatment of human papillomavirus (hpv)-infected cells
11/22/2001	WO2001087338A1 Immunomodulatory human mhc class ii antigen-binding polypeptides
11/22/2001	WO2001087337A1 Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells
11/22/2001	WO2001087330A2 Compositions and methods for achieving immune suppression
11/22/2001	WO2001087327A1 Method for cell adhesion and wound healing
11/22/2001	WO2001087302A1 Detection of antibodies to squalene in serum
11/22/2001	WO2001087286A2 Antisense enzyme inhibitors for improving pharmacokinetics of a drug
11/22/2001	WO2001087238A2 Induction of apoptosis and cell growth inhibition by protein 4.33
11/22/2001	WO2001087231A2 Methods and compositions for the diagnosis of schizophrenia
11/22/2001	WO2001087066A1 Vaccines, immunotherapeutics and methods for using the same
11/22/2001	WO2001087058A1 Chimeric mouse having immunity constructed by using human cd34-positive cells and use thereof
11/22/2001	WO2001087039A2 Treatment of neoplasia / transformation using pituitary tumor transforming gene 2
11/22/2001	WO2001087037A1 Methods for modulating the proliferation of hematopoietic cells
11/22/2001	WO2001055333A8 Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides
11/22/2001	WO2001042442A3 Activation of endogenous genes by genomic introduction of a replicon
11/22/2001	WO2001036977A3 Identification of disease markers involving mass-based-separation
11/22/2001	WO2001036650A3 An oncolytic adenovirus
11/22/2001	WO2001036639A3 Bt toxin receptors from lepidopteran insects and methods of use
11/22/2001	WO2001036476A3 Ing2, an iaps associated cell cycle protein, compositions and methods of use
11/22/2001	WO2001036463A3 Genes specifically expressed in human dendritic cells
11/22/2001	WO2001036462A3 Protein c derivatives
11/22/2001	WO2001035995A3 Tr3-specific binding agents and methods for their use
11/22/2001	WO2001035991A3 Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof
11/22/2001	WO2001034809A3 Staphylococcus epidermidis nucleic acids and proteins
11/22/2001	WO2001034805A3 Human vanilloid receptor gene
11/22/2001	WO2001034792A3 Compositions and methods for the diminution or elimination of various cancers
11/22/2001	WO2001034779A3 Human proteins with homology to carboxypeptidases and polynucleotides encoding the same
11/22/2001	WO2001032891A3 Human lipase
11/22/2001	WO2001032845A3 Methods for the preparation of (lipo)peptide synthetases and (lipo)peptides produced therewith
11/22/2001	WO2001031036A3 Modified viral surface proteins which bind to cells of tumor vasculature
11/22/2001	WO2001031035A3 Heterologous production of polyketides
11/22/2001	WO2001030989A3 Method for creating divergent populations of nucleic acid molecules and proteins
11/22/2001	WO2001030986A3 Human pif1 dna helicase and uses thereof
11/22/2001	WO2001030969A8 Stanniocalcin proteins and nucleic acids and methods based thereon
11/22/2001	WO2001029223A3 Type i membrane protein ztsl1
11/22/2001	WO2001027269A3 Vip54 protein and related materials
11/22/2001	WO2001027268A3 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
11/22/2001	WO2001027255A3 Nucleic acid coding for a ctage gene family, use and production thereof
11/22/2001	WO2001027146A3 Chemokine receptor
11/22/2001	WO2001023597A9 Cell lines and constructs useful in production of e1-deleted adenoviruses in absence of replication competent adenovirus
11/22/2001	WO2001021795A3 Fatty acid transport proteins
11/22/2001	WO2001021781A3 Methods for site-associated modification of gene activity and nucleic acid structure
11/22/2001	WO2001019993A3 Virulence genes of m. marinum and m. tuberculosis
11/22/2001	WO2001019976A3 Plant regulatory sequences for control of gene expression
11/22/2001	WO2001019380A3 Oncolytic virus
11/22/2001	WO2001018169A3 Agents and compositions and methods for diagnostic and/or treating or preventing plaque forming diseases
11/22/2001	WO2001014564A3 Polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby
11/22/2001	WO2001011063A3 Gene transfer combination vectors, method for the production and utilization thereof
11/22/2001	WO2001007637B1 Conditionally controlled, attenuated hiv vaccine
11/22/2001	WO2000055633A9 Methods of screening for colorectal cancer modulators
11/22/2001	WO2000047713A9 Genes encoding the 5h7 antibody and methods for conferring programmed cell death properties to cells
11/22/2001	WO2000014263A9 Recombinant hepatitis a virus (hav), hav variants, hav-based vaccines and methods of producing them
11/22/2001	US20010044941 For modulation of corn kernel development and protecting against stress and adverse environmental conditions
11/22/2001	US20010044939 Chimeric gene encodes acetolactate synthase in sense or antisense orientation; useful in development of herbicides, based on holoenzyme inhibition
11/22/2001	US20010044938 Stress tolerance and delayed senescence in plants
11/22/2001	US20010044937 Transgenic intracytoplasmic sperm injection, retroviral gene transfer, intracytoplasmic nuclear injection, and pronuclear injection; useful as models for human disease/diagnosis, assessing safety and efficiency of drug and gene therapy
11/22/2001	US20010044531 For probes, comprising a heterocycle condensed with a cyclic group such as ribofuranose derivative; biotin and 5-carboxyfluorescein derivatives
11/22/2001	US20010044528 5'-O-alkyl nucleotide, block of phosphodiester-linked 2'-O-alkyl ribonucleotides, a block of phosphorothioate-linked deoxyribonucleotides, and a blocking group for nuclease resistance; lipid-peptoid carrier
11/22/2001	US20010044523 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells
11/22/2001	US20010044522 Polypeptides, antibodies against them and nucleic acids encoding them; detecting activated CD4+ T-cells to diagnose a disease or condition of the immune system; screening for immunosuppressants
11/22/2001	US20010044521 Especially those present in inclusion bodies in bacterial hosts, by maintaining alkaline pH in presence of chaotrophic or reducing agents, and decreasing pH gradually over given time to induce renaturation; proteomics
11/22/2001	US20010044413 First nucleic acid molecule encoding cell growth stimulating agent, second nucleic acid encoding a bioactive agent, and a biocompatible substance capable of cellular infiltration; for systemic delivery of a bioactive agent

1 ... 2937 2938 2939 2940 2941 2942 2943 2944 2945 2946 2947 2948 2949 2950 2951 2952 2953 2954 2955 2956 2957 ... 4023